BERLIN, Sept. 19, 2008 (GLOBE NEWSWIRE) -- Corrected Voting Rights Notification:
In correction of the voting rights notification dated 10 September 2008 and released by Epigenomics AG on 11 September 2008, Federated Investors Inc., Pittsburgh, PA, USA on 18 September 2008 made the following corrected notification in the name and on behalf of Federated Equity Management Company of Pennsylvania, Pittsburgh, PA, USA pursuant to paragraph 21 para. 1 WpHG in connection with paragraph 22 para. 1 sent. 1 no. 6 WpHG regarding the holding of voting rights held in Epigenomics AG:
On 8 September 2008 Federated Equity Management Company of Pennsylvania exceeded the 20 per cent threshold of paragraph 21 para. 1 WpHG and held at this date 20.12 per cent of the voting rights (5,375,319 voting rights) in Epigenomics AG.
All 20.12 per cent of the voting rights (5,375,319 voting rights) are attributed to Federated Equity Management Company of Pennsylvania pursuant to paragraph 22 para. 1 sent. 1 no. 6 WpHG. Some of the voting rights are attributed to Federated Equity Management Company of Pennsylvania by Federated Kaufmann Fund which holds directly 3 per cent or more of the voting rights in Epigenomics AG.
Federated Investors Inc. is the parent company of F II Holdings Inc., which in turn is the parent company of Federated Equity Management Company of Pennsylvania. Federated Equity Management Company of Pennsylvania, an investment adviser registered in the United States under the Investment Company Act of 1940, acts as Investment Adviser to the Federated Kaufmann Fund and Federated Kaufmann Fund II, both Massachusetts Business Trusts and Investment Companies, as that term is defined under the Investment Company Act 1940, as amended.
Epigenomics AG The Executive Board